Synmosa Biopharma Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 1,257.73 million compared to TWD 966.67 million a year ago. Net income was TWD 126.07 million compared to TWD 125.13 million a year ago.

Basic earnings per share from continuing operations was TWD 0.3568 compared to TWD 0.3477 a year ago. Diluted earnings per share from continuing operations was TWD 0.3568 compared to TWD 0.3477 a year ago.